“There were no histological signs of rejection in Group D. A significant reduction in TAS was observed in tacrolimus treated animals in both syngeneic and allogeneic combinations (Groups B and D ), compared with controls (Groups A and C) (P < 0.001 and P < 0.01, respectively).”